|
Catalog Number UNK HIP FEMORAL STEM |
Device Problem
Appropriate Term/Code Not Available (3191)
|
Patient Problems
Edema (1820); Headache (1880); Nausea (1970); Pain (1994); Tissue Damage (2104); Vertigo (2134); Weakness (2145); Ambulation Difficulties (2544); Test Result (2695); Not Applicable (3189); No Code Available (3191)
|
Event Date 09/11/2013 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Investigation summary: the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa (b)(4).Ongoing post market surveillance is conducted per our procedures for this product.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Event Description
|
Asr (b)(6) claim letter received.For english translation.This complaint will be updated once english translation received.
|
|
Event Description
|
Claim letter alleges cellulite of the lower right limb, weakness, moderate signs of metallosis during revision, walking difficulties, edema, headache, nausea and vertigo.On (b)(6) 2013 x-rays reported of the pelvis and hips indicated moderate hyperostosis of the greater trochanter, small isolated calcification ossification in the soft tissues.On (b)(6) 2013 reported moderate perforation of the acetabular roof.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Additional narrative: product complaint # (b)(4).Investigation summary: the asr platform was voluntarily recalled from the market in (b)(6).2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa (b)(4).Ongoing post market surveillance is conducted per our procedures for this product.If information is obtained that was not available for the initial medwatch , a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|
|
|